• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药治疗原发性雷诺现象的疗效:随机对照试验的系统评价和 Meta 分析。

Effectiveness of Chinese herbal medicine for primary Raynaud's phenomenon: a systematic review and Meta-analysis of randomized controlled trials.

机构信息

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital University of Medicine Sciences, Beijing 100010, China.

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing100700, China.

出版信息

J Tradit Chin Med. 2020 Aug;40(4):509-517. doi: 10.19852/j.cnki.jtcm.2020.04.001.

DOI:10.19852/j.cnki.jtcm.2020.04.001
PMID:32744019
Abstract

OBJECTIVE

To evaluate the effectiveness of Chinese herbal medicine for primary Raynaud's phenomenon (PRP).

METHODS

The Cochrane Central Register of Controlled Trials, PubMed, Chinese Biomedical Literature Database, China National Knowledge Infrastructure, China Science and Technology Journal Database, and Wanfang Database were searched up to February 13, 2018. Randomized controlled trials (RCTs) on treatment of PRP with Chinese herbal medicine compared with placebo, blank control, lifestyle changes, or calcium antagonists were identified and reviewed. The quality of included trials was assessed using a risk of bias tool.

RESULTS

Eight RCTs involving 674 participants were included. The methodological quality of the included trials was generally poor. Meta-analysis of two trials showed that Buyang Huanwu Tang plus Danggui Sini Tang produced greater improvement in global symptoms than nifedipine. One trial showed that Danggui Sini Tang and a self-composed Chinese herbal medicine decoction, respectively, produced greater improvement in global symptoms than nifedipine alone. In one trial, modified Danggui Sini Tang showed greater improvement in global symptoms and arterial peak systolic velocity compared with nifedipine. One trial showed that Jiejing Tongmi Tang produced greater improvement in global symptoms, plasma endothelin, and plasma nitric oxide than cinepazide maleate injection. However, Jiejing Tongmi Tang did not produce a significant difference in skin temperature and peripheral artery blood stream drawing after cold pressor testing compared with cinepazide maleate injection. None of the trials reported frequency of attacks, duration of attacks, participant preference scores, or adverse events.

CONCLUSION

Chinese herbal medicine may have a positive effective on PRP. However, owing to weak methodology, the benefits of Chinese herbal medicine for PRP are inconclusive. More rigorously designed studies are needed to confirm these findings.

摘要

目的

评价中药治疗原发性雷诺现象(PRP)的疗效。

方法

检索 Cochrane 对照试验中心注册库、PubMed、中国生物医学文献数据库、中国知网、中国科技期刊数据库和万方数据库,搜集中药治疗 PRP 的随机对照试验,与安慰剂、空白对照、生活方式改变或钙通道阻滞剂比较。采用偏倚风险评估工具评价纳入研究的质量。

结果

纳入 8 项 RCT,共 674 例患者。纳入研究的方法学质量普遍较差。2 项试验的 Meta 分析结果显示,补阳还五汤联合当归四逆汤的整体症状改善优于硝苯地平。1 项试验显示,当归四逆汤和自拟中药汤剂分别优于硝苯地平单药治疗。1 项试验中,加味当归四逆汤在整体症状和动脉收缩期峰值速度方面的改善优于硝苯地平。1 项试验显示,接经通脉汤在整体症状、血浆内皮素和血浆一氧化氮方面的改善优于桂哌齐特。然而,与桂哌齐特相比,接经通脉汤在冷加压试验后皮肤温度和外周动脉血流描记方面无显著差异。所有试验均未报告发作频率、发作持续时间、患者偏好评分或不良反应。

结论

中药可能对 PRP 有积极作用。但是,由于方法学薄弱,中药治疗 PRP 的疗效尚不确定。需要更多设计严谨的研究来证实这些发现。

相似文献

1
Effectiveness of Chinese herbal medicine for primary Raynaud's phenomenon: a systematic review and Meta-analysis of randomized controlled trials.中药治疗原发性雷诺现象的疗效:随机对照试验的系统评价和 Meta 分析。
J Tradit Chin Med. 2020 Aug;40(4):509-517. doi: 10.19852/j.cnki.jtcm.2020.04.001.
2
Vascular response of Raynaud's phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): a preliminary study.雷诺现象对硝苯地平或草药(独活寄生汤合当归四逆汤)的血管反应:一项初步研究。
Chang Gung Med J. 2008 Sep-Oct;31(5):492-502.
3
Calcium channel blockers for primary Raynaud's phenomenon.用于原发性雷诺现象的钙通道阻滞剂。
Cochrane Database Syst Rev. 2016 Feb 25;2(2):CD002069. doi: 10.1002/14651858.CD002069.pub5.
4
Calcium channel blockers for primary Raynaud's phenomenon.用于原发性雷诺现象的钙通道阻滞剂。
Cochrane Database Syst Rev. 2014 Jan 30(1):CD002069. doi: 10.1002/14651858.CD002069.pub4.
5
Herbal Medicines for Cold Hypersensitivity in the Hands and Feet: A Systematic Review and Meta-Analysis.草药治疗手足发冷过敏:系统评价和荟萃分析。
J Altern Complement Med. 2018 Dec;24(12):1150-1158. doi: 10.1089/acm.2018.0009. Epub 2018 Jul 11.
6
Chinese herbal medicine for diabetic peripheral neuropathy.用于治疗糖尿病周围神经病变的中草药
Cochrane Database Syst Rev. 2011 Jun 15(6):CD007796. doi: 10.1002/14651858.CD007796.pub2.
7
Oral traditional Chinese medication for adhesive small bowel obstruction.口服中药治疗粘连性小肠梗阻。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008836. doi: 10.1002/14651858.CD008836.pub2.
8
Effectiveness and safety of Suxiao Jiuxin pill in treating acute coronary syndrome: a systematic review and Meta-analysis.速效救心丸治疗急性冠状动脉综合征的有效性和安全性:系统评价和 Meta 分析。
J Tradit Chin Med. 2020 Aug;40(4):518-529. doi: 10.19852/j.cnki.jtcm.2020.04.002.
9
Chinese herbal medicine Buyang Huanwu Decoction combined with acupuncture to treat sequela of apoplexy: a meta-analysis of randomized controlled trials.中药补阳还五汤联合针刺治疗中风后遗症的疗效:一项随机对照试验的荟萃分析。
Ann Palliat Med. 2021 Feb;10(2):1685-1692. doi: 10.21037/apm-20-1092. Epub 2020 Nov 18.
10
The efficacy and safety of Chinese herbal medicine, Rhodiola formulation in treating ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials.中药红景天制剂治疗缺血性心脏病的疗效与安全性:一项随机对照试验的系统评价与Meta分析
Complement Ther Med. 2014 Aug;22(4):814-25. doi: 10.1016/j.ctim.2014.05.001. Epub 2014 Jun 9.

引用本文的文献

1
Cold responses and hormonal echoes: a comprehensive view of Raynaud's vascular dysfunction.寒冷反应与激素回声:雷诺氏血管功能障碍的全面视角
Inflammopharmacology. 2025 Jun 12. doi: 10.1007/s10787-025-01792-0.
2
Understanding Traditional Chinese Medicine Therapeutics: An Overview of the Basics and Clinical Applications.理解中医治疗学:基础与临床应用概述
Healthcare (Basel). 2021 Mar 1;9(3):257. doi: 10.3390/healthcare9030257.